Logo Sandoz bleu HD_EN
Sandoz Canada launches two easy-to-use products: Salinex(R) Seawater nasal spray for daily care and Ezeva(TM) zinc oxide cream
07 déc. 2015 12h51 HE | Sandoz Canada
Lire la version française BOUCHERVILLE, Quebec, Dec. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of two easy-to-use products: Salinex® Seawater to help reduce...
Sandoz Logo
Sandoz Canada Launches a New Concentration of (T/C)Lorazepam Injection USP
02 déc. 2015 19h54 HE | Sandoz Canada
Lire la version française BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of (T/C)Lorazepam Injection USP 2 mg/mL, a new concentration...
SANDOZ_AN_bleu
Sandoz Canada Launches a New Concentration of T/CLorazepam Injection USP
02 déc. 2015 14h19 HE | Sandoz Canada
Lire la version française BOUCHERVILLE, Quebec, Dec. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada is pleased to announce the launch of T/CLorazepam Injection USP 2 mg/mL, a new concentration now...
Sandoz Logo
Sandoz Canada launches new multi-platform application to show real-time availability of its injectable medicines
14 oct. 2015 13h28 HE | Sandoz Canada
Version française BOUCHERVILLE, Quebec, Oct. 14, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada, which established a milestone in transparency by providing the first national report on availability...
SANDOZ_AN_bleu
Sandoz Canada launches PrSandoz(R) Solifenacin on the Canadian market for the treatment of urinary urgency, frequency and incontinence
07 oct. 2015 16h41 HE | Sandoz Canada
Version française BOUCHERVILLE, QC, Oct. 7, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of a new drug on the Canadian market, PrSandoz® Solifenacin (solifenacin...
BenDesjardins2015_0016
Sandoz Canada Celebrates Its 10th Anniversary!
25 sept. 2015 09h15 HE | Sandoz Canada
Lire la version française BOUCHERVILLE, Quebec, Sept. 25, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. celebrated its 10th anniversary on September 19 this year with a colourful event in...
Sandoz Logo
Health Canada Approves New Indications for PrOmnitrope(R) (Somatropin), Canada's First Subsequent Entry Biologic (Biosimilar)
02 sept. 2015 16h11 HE | Sandoz Canada
Click here for the French version. BOUCHERVILLE, Quebec, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Sandoz Canada Inc., a Novartis company, has received approval from Health Canada for a number of...
Amiodarone_Syringe
Sandoz Canada launches PrAmiodarone Syringe for the treatment of several heart rhythm disorders
20 août 2015 16h42 HE | Sandoz Canada
BOUCHERVILLE, Quebec, Aug. 20, 2015 (GLOBE NEWSWIRE) -- Version française Sandoz Canada Inc., a Novartis company, continues to innovate with the launch of PrAmiodarone Syringe (PrAmiodarone...